Texas 2019 - 86th Regular

Texas House Bill HCR76 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	H.C.R. No. 76
	1	+	By: Price (Senate Sponsor - Kolkhorst) H.C.R. No. 76
	2	+	(In the Senate - Received from the House May 13, 2019;
	3	+	May 14, 2019, read first time and referred to Committee on
	4	+	Administration; May 19, 2019, reported favorably by the following
	5	+	vote: Yeas 5, Nays 0; May 19, 2019, sent to printer.)
	6	+	Click here to see the committee vote
2	7
3	8
4	9		HOUSE CONCURRENT RESOLUTION
5	10		WHEREAS, Tardive dyskinesia (TD) is a condition
6	11		characterized by involuntary movements of the face, trunk, or
7	12		extremities, caused by long-term use of dopamine receptor-blocking
8	13		agents; and
9	14		WHEREAS, A movement disorder, TD is most commonly associated
10	15		with facial symptoms such as uncontrolled grimacing, abnormal
11	16		motions of the lips and tongue, and rapid blinking, but may also
12	17		manifest in other parts of the body; it occurs in patients who have
13	18		been prescribed neuroleptic medications for schizophrenia, bipolar
14	19		disorder, other neurological conditions, and gastrointestinal
15	20		disorders, and it can persist after individuals discontinue use of
16	21		the drugs; and
17	22		WHEREAS, Patients living with TD frequently suffer from
18	23		embarrassment due to their involuntary movements, which may create
19	24		a sense of discomfort and unease in those around them; these
20	25		struggles often compound the difficulties that individuals with TD
21	26		already face while being treated for psychiatric and mood
22	27		disorders, leading them to further isolate themselves from others;
23	28		the condition can also make it challenging for patients to work and
24	29		stay active and productive; and
25	30		WHEREAS, TD is estimated to affect at least 500,000 people in
26	31		the United States, and it is more prevalent among postmenopausal
27	32		women, patients over the age of 55, and those with a history of
28	33		alcohol or substance abuse; it is important that patients be
29	34		diagnosed as early as possible to ensure the best outcome, and at
30	35		this time, prevention remains the best-established method for
31	36		combatting the condition; and
32	37		WHEREAS, Awareness among patients, medical professionals,
33	38		caregivers, and the public can play a crucial role in helping more
34	39		people to live lives free of TD and the challenges and stigma
35	40		associated with it, and the observance of TD Awareness Week in May
36	41		2019 will assist in promoting much-needed education on this
37	42		important health issue; now, therefore, be it
38	43		RESOLVED, That the 86th Legislature of the State of Texas
39	44		hereby designate the first full week of May as TD Awareness Week and
40	45		encourage all Texans to learn more about the risk factors and signs
41	46		of tardive dyskinesia; and, be it further
42	47		RESOLVED, That, in accordance with the provisions of Section
43	48		391.004(d), Government Code, this designation remain in effect
44	49		until the 10th anniversary of the date this resolution is finally
45	50		passed by the legislature.
46		-	Price
47		-	______________________________ ______________________________
48		-	President of the Senate Speaker of the House
49		-	I certify that H.C.R. No. 76 was adopted by the House on May
50		-	10, 2019, by the following vote: Yeas 138, Nays 2, 2 present, not
51		-	voting.
52		-	______________________________
53		-	Chief Clerk of the House
54		-	I certify that H.C.R. No. 76 was adopted by the Senate on May
55		-	22, 2019, by the following vote: Yeas 31, Nays 0.
56		-	______________________________
57		-	Secretary of the Senate
58		-	APPROVED: __________________
59		-	Date
60		-	__________________
61		-	Governor
	51	+	* * * * *